NDSN

NDSN
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $741.509M ▲ | $218.75M ▲ | $125.784M ▲ | 16.963% ▲ | $2.22 ▲ | $223.228M ▲ |
| Q2-2025 | $682.938M ▲ | $205.154M ▲ | $112.404M ▲ | 16.459% ▲ | $1.98 ▲ | $202.919M ▲ |
| Q1-2025 | $615.42M ▼ | $194.949M ▼ | $94.652M ▼ | 15.38% ▼ | $1.66 ▼ | $180.445M ▼ |
| Q4-2024 | $744.482M ▲ | $223.932M ▲ | $122.168M ▲ | 16.41% ▼ | $2.12 ▲ | $213.171M ▲ |
| Q3-2024 | $661.604M | $201.943M | $117.327M | 17.734% | $2.05 | $201.619M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $147.788M ▲ | $6.01B ▼ | $3.028B ▼ | $2.982B ▲ |
| Q2-2025 | $130.157M ▼ | $6.062B ▲ | $3.102B ▲ | $2.96B ▲ |
| Q1-2025 | $130.424M ▲ | $5.872B ▼ | $2.995B ▼ | $2.877B ▼ |
| Q4-2024 | $115.952M ▼ | $6.001B ▲ | $3.069B ▲ | $2.932B ▲ |
| Q3-2024 | $165.324M | $5.204B | $2.351B | $2.854B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $125.784M ▲ | $237.972M ▲ | $-17.63M ▼ | $-203.717M ▼ | $17.631M ▲ | $226.409M ▲ |
| Q2-2025 | $112.404M ▲ | $119.17M ▼ | $-12.824M ▲ | $-113.231M ▲ | $-267K ▼ | $103.13M ▼ |
| Q1-2025 | $94.652M ▼ | $159.122M ▲ | $-14.276M ▲ | $-127.582M ▼ | $14.472M ▲ | $137.723M ▲ |
| Q4-2024 | $122.168M ▲ | $96.381M ▼ | $-809.508M ▼ | $665.107M ▲ | $-49.372M ▼ | $75.757M ▼ |
| Q3-2024 | $117.327M | $164.848M | $-19.713M | $-104.855M | $39.878M | $142.969M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Advanced Technology Systems | $120.00M ▲ | $150.00M ▲ | $120.00M ▼ | $160.00M ▲ |
Industrial Precision Solutions | $370.00M ▲ | $390.00M ▲ | $300.00M ▼ | $320.00M ▲ |
Medical And Fluid Solutions | $170.00M ▲ | $200.00M ▲ | $190.00M ▼ | $200.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Nordson looks like a high-quality, niche industrial company with durable strengths and some emerging trade-offs. On the positive side, it offers steady revenue growth, strong margins, robust and reliable cash flow, and a deep competitive moat rooted in precision technology, patents, and long-standing customer relationships. Its innovation pipeline is tied to attractive long-term themes such as advanced electronics, medical devices, electric vehicles, and precision agriculture. On the risk side, earnings momentum has flattened, leverage has increased as the company has grown through acquisitions, and higher debt levels raise sensitivity to economic and interest-rate conditions. The overall picture is of a well-run, innovation-driven industrial franchise that is leaning more on its balance sheet to pursue growth while working to maintain its historically strong profitability profile.
NEWS
October 21, 2025 · 8:00 AM UTC
Nordson Publishes Its 2025 Corporate Responsibility Update, Highlights Progress on Key Social and Environmental Initiatives
Read more
September 2, 2025 · 11:12 AM UTC
Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities
Read more
About Nordson Corporation
https://www.nordson.comNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS).
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $741.509M ▲ | $218.75M ▲ | $125.784M ▲ | 16.963% ▲ | $2.22 ▲ | $223.228M ▲ |
| Q2-2025 | $682.938M ▲ | $205.154M ▲ | $112.404M ▲ | 16.459% ▲ | $1.98 ▲ | $202.919M ▲ |
| Q1-2025 | $615.42M ▼ | $194.949M ▼ | $94.652M ▼ | 15.38% ▼ | $1.66 ▼ | $180.445M ▼ |
| Q4-2024 | $744.482M ▲ | $223.932M ▲ | $122.168M ▲ | 16.41% ▼ | $2.12 ▲ | $213.171M ▲ |
| Q3-2024 | $661.604M | $201.943M | $117.327M | 17.734% | $2.05 | $201.619M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $147.788M ▲ | $6.01B ▼ | $3.028B ▼ | $2.982B ▲ |
| Q2-2025 | $130.157M ▼ | $6.062B ▲ | $3.102B ▲ | $2.96B ▲ |
| Q1-2025 | $130.424M ▲ | $5.872B ▼ | $2.995B ▼ | $2.877B ▼ |
| Q4-2024 | $115.952M ▼ | $6.001B ▲ | $3.069B ▲ | $2.932B ▲ |
| Q3-2024 | $165.324M | $5.204B | $2.351B | $2.854B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $125.784M ▲ | $237.972M ▲ | $-17.63M ▼ | $-203.717M ▼ | $17.631M ▲ | $226.409M ▲ |
| Q2-2025 | $112.404M ▲ | $119.17M ▼ | $-12.824M ▲ | $-113.231M ▲ | $-267K ▼ | $103.13M ▼ |
| Q1-2025 | $94.652M ▼ | $159.122M ▲ | $-14.276M ▲ | $-127.582M ▼ | $14.472M ▲ | $137.723M ▲ |
| Q4-2024 | $122.168M ▲ | $96.381M ▼ | $-809.508M ▼ | $665.107M ▲ | $-49.372M ▼ | $75.757M ▼ |
| Q3-2024 | $117.327M | $164.848M | $-19.713M | $-104.855M | $39.878M | $142.969M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Advanced Technology Systems | $120.00M ▲ | $150.00M ▲ | $120.00M ▼ | $160.00M ▲ |
Industrial Precision Solutions | $370.00M ▲ | $390.00M ▲ | $300.00M ▼ | $320.00M ▲ |
Medical And Fluid Solutions | $170.00M ▲ | $200.00M ▲ | $190.00M ▼ | $200.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Nordson looks like a high-quality, niche industrial company with durable strengths and some emerging trade-offs. On the positive side, it offers steady revenue growth, strong margins, robust and reliable cash flow, and a deep competitive moat rooted in precision technology, patents, and long-standing customer relationships. Its innovation pipeline is tied to attractive long-term themes such as advanced electronics, medical devices, electric vehicles, and precision agriculture. On the risk side, earnings momentum has flattened, leverage has increased as the company has grown through acquisitions, and higher debt levels raise sensitivity to economic and interest-rate conditions. The overall picture is of a well-run, innovation-driven industrial franchise that is leaning more on its balance sheet to pursue growth while working to maintain its historically strong profitability profile.
NEWS
October 21, 2025 · 8:00 AM UTC
Nordson Publishes Its 2025 Corporate Responsibility Update, Highlights Progress on Key Social and Environmental Initiatives
Read more
September 2, 2025 · 11:12 AM UTC
Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities
Read more

CEO
Sundaram Nagarajan
Compensation Summary
(Year 2024)

CEO
Sundaram Nagarajan
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2011-04-13 | Forward | 2:1 |
| 2000-09-13 | Forward | 2:1 |
| 1991-09-25 | Forward | 2:1 |
| 1987-05-01 | Forward | 3:2 |
| 1984-01-04 | Forward | 3:2 |
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
6.071M Shares
$1.443B

BLACKROCK INC.
3.872M Shares
$920.133M

BLACKROCK, INC.
3.842M Shares
$913.176M

STATE STREET CORP
2.864M Shares
$680.738M

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
2.463M Shares
$585.328M

BLACKROCK FUND ADVISORS
2.069M Shares
$491.732M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
1.668M Shares
$396.352M

GEODE CAPITAL MANAGEMENT, LLC
1.518M Shares
$360.69M

MORGAN STANLEY
1.49M Shares
$354.034M

LAZARD ASSET MANAGEMENT LLC
1.299M Shares
$308.823M

JANUS HENDERSON INVESTORS US LLC
1.182M Shares
$281.017M

MUNDER CAPITAL MANAGEMENT
1.165M Shares
$276.919M

MASSACHUSETTS FINANCIAL SERVICES CO /MA/
1.067M Shares
$253.561M

INVESCO LTD.
970.923K Shares
$230.75M

ATLANTA CAPITAL MANAGEMENT CO L L C
898.691K Shares
$213.583M

FMR LLC
890.453K Shares
$211.625M

PROSHARE ADVISORS LLC
773.547K Shares
$183.841M

GOLDMAN SACHS GROUP INC
754.263K Shares
$179.258M

VAN ECK ASSOCIATES CORP
743.386K Shares
$176.673M

JPMORGAN CHASE & CO
718.616K Shares
$170.786M
Summary
Only Showing The Top 20






